MedTrace Logo

Interdisciplinary + Intersectoral Telemedicine Evaluation, Coordination + Treatment in RhineMain+ Parkinson's Network

NCT06479083 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1354

Last updated 2025-07-23

No results posted yet for this study

Summary

Project objective: To improve the health care of Parkinson's disease patients in the ParkinsonNetz RheinMain+.

Hypothesis: Through the interdisciplinary and cross- sectoral networking in a tele medical network and the coordinating function of an "advanced practice nurse" (APN) specially trained for Parkinson's disease, the process quality within the network is increased and the individual health status is positively influenced.

Conditions

  • Parkinson Disease

Interventions

OTHER

New Intervention form including

The central element of the new form of care is the implementation of a tele medical evaluation and coordination function, which controls individualized treatment processes within the network. The individualized evaluation and coordination of treatment paths is carried out within the already existing Parkinson's network RheinMain+ by a non-physician medical specialist (APN) specially trained for the indication Parkinson's disease.

OTHER

Standard treatment

The standard treatment which all compulsory insured patients get.

Sponsors & Collaborators

  • Hochschule für Wirtschaft und Gesellschaft Ludwigshafen Institut für Management, Ökonomie und Versorgung im Gesundheitsbereich

    collaborator UNKNOWN

  • Katholische Hochschule Mainz Fachbereich Gesundheit und Pflege

    collaborator UNKNOWN

  • Universitätsklinikum Frankfurt Zentrum der Neurologie und Neurochirurgie

    collaborator UNKNOWN

  • Techniker Krankenkasse Landesvertretung Rheinland-Pfalz

    collaborator UNKNOWN

  • DAK-Gesundheit Landesvertretung Rheinland-Pfalz und Saarland

    collaborator UNKNOWN

  • Johannes Gutenberg University Mainz

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-10-31
Completion
2027-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06479083 on ClinicalTrials.gov